BLOG POST
Traditional HCP marketing often fails to align with real-world clinical decision windows. Phreesia’s ProviderConnect aligns life sciences messaging to real patient appointments and near-term clinical moments, with a privacy-first approach that helps brands engage clinicians when it matters most.
Much of healthcare marketing still treats past prescribing behavior as if it is the cleanest and most dependable signal of future clinical need. That’s because claims data is structured, familiar and measurable, and it can be segmented by specialty, geography and volume. Even when refreshed in real time, however, it remains a lagging indicator because it reflects patients who have already been seen. It tells you what was done, not what is about to be needed.
Take early spring, for example, when respiratory viral season winds down. Many clinicians felt the shift before any quarterly report captured it. Schedules that were packed with “cough,” “fever” and “shortness of breath” begin to change. In primary care and hospital medicine, the focus moves from acute infections and exacerbations to post-viral complications, medication lapses and chronic disease catch up. A clinician who escalated inhalers or prescribed antivirals in January may now be reassessing maintenance regimens and stabilizing patients whose chronic conditions were destabilized over the winter. The specialty has not changed; the cognitive task has. Past prescribing patterns rarely capture that pivot in real time.
The challenge: Retrospective data is misaligned with the next decision window
Prescribing data can help describe broad utilization patterns. At the point where care decisions are actually made, the data are often clinically thin. The “why” behind a prescription is nuanced, patient panels are dynamic and the absence of a prescription may reflect access barriers more than clinical preference. Most importantly, historical encounters do not reliably predict what will appear on next week’s schedule.
Consider a few common realities:
- Referral and network flows shift quickly: Shifts in payer contracts, referral patterns or staffing changes and patient mix can look different within weeks. Prescribing history rarely keeps pace with those transitions.
- Disease progression and life events alter clinical trajectories: Patients age into new risk categories, develop comorbidities, experience side effects, lose insurance or stop medications. The next visit is shaped by what has changed, not what was prescribed before.
- Access friction distorts prescribing signals: Formularies, prior authorizations and affordability influence what gets written and filled, meaning prescribing often reflects feasibility rather than preference.
- Scope of practice is broader than assumed: At the same time, many clinicians function broadly within their field, especially in underserved areas, further widening the gap between past utilization and future need.
Of course, there are certainly clinicians whose scope is narrower, such as highly subspecialized physicians or advanced practice clinicians focused on one slice of care, so one would not expect their prescribing habits to change. But even highly subspecialized clinicians are not immune to this mismatch. Guidelines evolve, indications expand, safety evidence shifts monitoring requirements and therapies move within treatment algorithms. A clinician who did not prescribe a therapy last year may be precisely the clinician who needs updated information now because the evidence or eligibility criteria changed.
This is the core problem: if information does not connect to the patients clinicians are about to see, it competes with everything else and is often deprioritized. When it aligns with an active decision window, it has a far greater chance of being considered and applied.
The solution: Move from historical proxies to appointment-informed relevance
A more clinically aligned approach begins with a simple reframing: future need is driven by upcoming encounters. If the goal is to support care decisions, the most meaningful signal is not what a clinician prescribed in the past, but what that clinician is preparing to manage next.
For life sciences organizations and media partners, this is not just a messaging challenge. It is a data strategy challenge. If audience models are built primarily on retrospective claims and prescribing data, then even advanced AI is optimizing against a historical snapshot. The model may be precise, but it is precise about yesterday.
Clinical readiness is forward-looking. It is visible in scheduled appointments, visit types and condition-level context that signal what a clinician is preparing to address in the near term. Information related to upcoming encounters offers a fundamentally different input into targeting models. They shift audience construction from inference based on prior behavior to alignment with imminent care.
Many solutions emphasize point-of-care engagement and workflow integration. Those approaches matter. The question is how “the moment that matters” is defined. If engagement occurs only after a patient is already in the room and a decision is underway, the opportunity for preparation is limited. When content aligns with upcoming appointments, it can support clinical thinking before the visit begins.
In practical terms, that means educational resources can surface as clinicians review schedules, prepare for follow-ups and anticipate therapeutic decisions. It means information about updated guidelines, new indications or access pathways can be encountered when there is still time to shape a plan rather than react to one. It allows clinicians, nurse practitioners, physician assistants and pharmacists to proactively consider monitoring needs, cost implications and patient counseling before a prescription is written.
For broad-scope clinicians, this is especially relevant. The cognitive load of modern practice is not simply keeping up with one therapeutic area but managing multiple conditions in compressed timeframes. A single morning can include asthma management, anticoagulation decisions, diabetes intensification and evaluation of new neurologic symptoms. Historical prescribing patterns do not reflect that variability. Their schedule does.
The opportunity: Relevance that aligns with clinical care
Clinicians do not need more content. They need information that arrives when it is clinically useful.
Appointments are shorter and administrative burden is heavier. The pace of medical advancement continues to accelerate. Across care teams, the bottleneck is not exposure to information. It is relevance at the moment of decision.
When engagement aligns with real decision windows, brands are not simply increasing impressions. They are increasing the likelihood that information is absorbed, discussed with patients and translated into action. That alignment requires signals that reflect what is about to happen in practice, not just what has already occurred.
Past prescribing behavior will always tell part of the story, but it is a story about yesterday. Clinical need is shaped by what is next: the upcoming visits, the patients about to be seen and the decisions that will be made in the near term.
Explore how ProviderConnect enables life sciences organizations to shift from historical proxies to future-informed HCP targeting, using privacy-safe data tied to upcoming appointments to engage clinicians when readiness is highest.
Alicia Cowley, MD, MBA, is an internist and Medical Director at Phreesia.
